Salarius Pharmaceuticals Inc Stock price
Is Salarius Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Salarius Pharmaceuticals Inc Stock Analysis
Analyst Opinions
6 Analysts have issued a Salarius Pharmaceuticals Inc forecast:
Analyst Opinions
6 Analysts have issued a Salarius Pharmaceuticals Inc forecast:
Don't miss a Thing! We will send you all news about Salarius Pharmaceuticals Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius' clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need. The company was founded in 2014 and is headquartered in Houston, TX.
| Head office | United States |
| CEO | Mr. Rosenblum |
| Employees | 2 |
| Founded | 2014 |
| Website | salariuspharma.com |


